Open access
Sep 2026
DNA methylation status at diagnosis in MDS predicts response to azacitidine.
Epigenetic signatures at distal genomic elements provide superior predictive power for AZA response compared to promoter-centric or transcriptional analyses, and establish a robust framework for personalized treatment strategies in MDS.
Qin Yang, M. Torres-Martín, M. Taguchi et al.
· Journal of Clinical Investig... · 0 citations